Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuta Yamaguchi

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Cancer Immunology, Immunotherapy : CII|October 13, 2025
CAR NK cell production from human cord blood NK progenitor cells is enhanced by stimulation of the IL-15 receptorYosuke Kogue, Shunya Ikeda, Yuto Maehara, et al.
The Journal of Infection|January 27, 2021
Predicting recurrence of respiratory failure in critically ill patients with COVID-19: A preliminary studyYuichi Adachi, Takayuki Shiroyama, Yuta Yamaguchi, et al.
Optics Express|January 7, 2010
Ultra-fast switching of light by absorption saturation in vacuum ultra-violet regionHitoki Yoneda, Yuichi Inubushi, Toshihiro Tanaka, et al.
Biochemical and Biophysical Research Communications|January 19, 2024
Cancer-associated SNRPD3 mutation confers resistance to hypoxia, which is attenuated by DRP1 inhibitionShingo Satoh, Kotaro Miyake, Yuichi Adachi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2024
[Sequential therapy with inotuzumab ozogamicin followed by CAR T-cell therapy for Philadelphia chromosome-negative acute lymphoblastic leukemia]Yo Mizutani, Shinsuke Kusakabe, Kentaro Fukushima, et al.
International Immunology|August 23, 2022
The proliferative activity levels of each immune cell population evaluated by mass cytometry are linked to the clinical phenotypes of systemic lupus erythematosusAkiko Kajihara, Takayoshi Morita, Yasuhiro Kato, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2023
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patientsJonas Nørskov Søndergaard, Janyerkye Tulyeu, Ryuya Edahiro, et al.
Modern Rheumatology Case Reports|October 22, 2020
Recovery from prolonged thrombocytopenia in patients with TAFRO syndrome: case series and literature reviewYuta Yamaguchi, Yuichi Maeda, Takayuki Shibahara, et al.
Vaccine|October 13, 2025
Distinct trajectories of humoral immune responses after SARS-CoV-2 mRNA vaccination in autoimmune inflammatory rheumatic diseases: A group-based trajectory analysisYuta Yamaguchi, Saori Amiya, Shoichiro Inokuchi, et al.
The Lancet Regional Health. Western Pacific|December 26, 2022
Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in JapanYuta Yamaguchi, Shinichiro Nameki, Yasuhiro Kato, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Cancer Immunology, Immunotherapy : CII|October 13, 2025
CAR NK cell production from human cord blood NK progenitor cells is enhanced by stimulation of the IL-15 receptorYosuke Kogue, Shunya Ikeda, Yuto Maehara, et al.
The Journal of Infection|January 27, 2021
Predicting recurrence of respiratory failure in critically ill patients with COVID-19: A preliminary studyYuichi Adachi, Takayuki Shiroyama, Yuta Yamaguchi, et al.
Optics Express|January 7, 2010
Ultra-fast switching of light by absorption saturation in vacuum ultra-violet regionHitoki Yoneda, Yuichi Inubushi, Toshihiro Tanaka, et al.
Biochemical and Biophysical Research Communications|January 19, 2024
Cancer-associated SNRPD3 mutation confers resistance to hypoxia, which is attenuated by DRP1 inhibitionShingo Satoh, Kotaro Miyake, Yuichi Adachi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2024
[Sequential therapy with inotuzumab ozogamicin followed by CAR T-cell therapy for Philadelphia chromosome-negative acute lymphoblastic leukemia]Yo Mizutani, Shinsuke Kusakabe, Kentaro Fukushima, et al.
International Immunology|August 23, 2022
The proliferative activity levels of each immune cell population evaluated by mass cytometry are linked to the clinical phenotypes of systemic lupus erythematosusAkiko Kajihara, Takayoshi Morita, Yasuhiro Kato, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2023
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patientsJonas Nørskov Søndergaard, Janyerkye Tulyeu, Ryuya Edahiro, et al.
Modern Rheumatology Case Reports|October 22, 2020
Recovery from prolonged thrombocytopenia in patients with TAFRO syndrome: case series and literature reviewYuta Yamaguchi, Yuichi Maeda, Takayuki Shibahara, et al.
Vaccine|October 13, 2025
Distinct trajectories of humoral immune responses after SARS-CoV-2 mRNA vaccination in autoimmune inflammatory rheumatic diseases: A group-based trajectory analysisYuta Yamaguchi, Saori Amiya, Shoichiro Inokuchi, et al.
The Lancet Regional Health. Western Pacific|December 26, 2022
Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in JapanYuta Yamaguchi, Shinichiro Nameki, Yasuhiro Kato, et al.
Pageof 5